MA-VERACODE
21.4.2022 17:52:05 CEST | Business Wire | Press release
Veracode , a leading global provider of application security testing (AST) solutions, today announced it has been positioned as a Leader for the ninth consecutive time in the 2022 Gartner Inc. Magic Quadrant for Application Security Testing1 . The company is the only vendor recognized as a Leader every single year since the report was first published.
“Since Veracode launched in 2006, we have played a significant role in shaping the application security market,” said Sam King, Chief Executive Officer at Veracode. “To be recognized as a Leader every single year, in our opinion, is a validation of our rich heritage, continued innovation, and strong vision for the future of software security and development. With cybersecurity taking center stage for enterprises across all industries, we’re proud to be a trusted partner for our customers, enabling them to bring development and security teams together to build and deliver secure software at the speed that business demands.”
According to Gartner, Veracode is recognized for its completeness of vision and ability to execute in the AST market. The company has also been identified in Gartner Peer Insights™ as a Customers’ Choice for Application Security Testing 2 , which is based on feedback and ratings from independent customer reviews.
Brian Roche, Chief Product Officer at Veracode, said, “The rapid acceleration of digital transformation, combined with increased software supply chain complexity and new cybersecurity regulations, means software security has never been more vital. Over the past year, we have focused heavily on geographical expansion with our European Region instance, and delivered new technologies, such as API Scanning, that address some of our customers’ biggest pain points. Our own platform evolution initiatives give us a deep understanding and appreciation for the challenges many of our customers face in their own digital transformation journeys, improving our capacity to function as a trusted advisor.”
Veracode’s comprehensive platform offers multiple testing types and integrates into popular development tools through a frictionless interface, providing a 360-degree view of application security posture. The company credits its position in the report to a laser focus on the transformation of its platform, launch of API Scanning, authentication management in dynamic analysis, and its static analysis and software composition analysis (SCA) capabilities Veracode’s SCA product uses natural language processing and machine learning to accurately identify vulnerabilities from multiple sources in open-source libraries. Through this proprietary process, the Veracode solution has identified hundreds of previously undetected vulnerabilities in open-source libraries in the last year alone.
In 2021, Veracode launched the Veracode European Region instance to support EU data residency requirements. The underlying platform has been leveraged to underpin Veracode’s much-anticipated FedRAMP instance, which will be introduced in the coming months.
“It’s a truly exciting time for Veracode. We have just announced a significant growth investment from TA Associates with a $2.5 billion valuation—a major milestone in our 16-year history—and look forward to a year of continued innovation and accelerating growth. We remain tirelessly committed to our mission of securing the software that powers our customers’ businesses, and our continued position as a Leader is, in our opinion, a testament to the passion and dedication of our team around the world,” King added.
To download a complimentary copy of the full 2022 Gartner Magic Quadrant Report, visit: https://info.veracode.com/2022-gartner-mq-gated.html
To learn more about application security from Veracode, please visit: https://www.veracode.com/products
1
Gartner, “Magic Quadrant for Application Security Testing” by Dale Gardner, Mark Horvath, Dionisio Zumerle, 18 April 2022.
2
Gartner, “Peer Insights ‘Voice of the Customer’: Application Security Testing” by Peer Contributors, 27 October 2021.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner and Peer Insights are trademarks of Gartner, Inc. and/or its affiliates. All rights reserved. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
Gartner Peer Insights Customers’ Choice constitute the subjective opinions of individual end-user reviews, ratings, and data applied against a documented methodology; they neither represent the views of, nor constitute an endorsement by, Gartner or its affiliates.
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved
About Veracode
Veracode is a leading AppSec partner for creating secure software, reducing the risk of security breach, and increasing security and development teams’ productivity. As a result, companies using Veracode can move their business, and the world, forward. With its combination of process automation, integrations, speed, and responsiveness, Veracode helps companies get accurate and reliable results to focus their efforts on fixing, not just finding, potential vulnerabilities. Learn more at www.veracode.com , on the Veracode blog and on Twitter .
Copyright © 2022 Veracode, Inc. All rights reserved. All other brand names, product names, or trademarks belong to their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220421005866/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 07:00:00 CEST | Press release
World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1 Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1 In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2 At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at e
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 04:00:00 CEST | Press release
Clinical evidence–backed postbiotic supports mood and well-being with formulation flexibility for diverse applications Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing aw
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 02:00:00 CEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release
Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom